Discover how targeting USP14 and UCHL5 enzymes offers breakthrough potential for treating Waldenström's Macroglobulinemia, a rare blood cancer.
Exploring how targeting deubiquitinating enzymes (DUBs) associated with the proteasome could revolutionize ovarian cancer treatment by overcoming drug resistance.
Exploring how mutant UBB+1 protein hijacks cellular cleanup mechanisms in neurodegenerative diseases by targeting deubiquitinating enzymes (DUBs)
Exploring how deubiquitinating enzyme inhibitors could revolutionize cervical cancer treatment by targeting the cell's protein recycling system.